Atlas Trials

Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.

Clinical trial NCT03857256 · COMPLETED

Trial details

NCT number
NCT03857256
Sponsor
Montreal Heart Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperlipidemias
Start date
2019-05-31
Primary completion
2021-08-31
Enrollment
263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.